-
The woman in your exam room says she has severe headaches that usually begin about two days before her menstrual cycle. When they occur, they get more severe in intensity. She does not report any signs of neurological aura, such as flashing lights or tingling sensations, with the headaches. What's your diagnosis?
-
When it comes to emergency contraception (EC), what does your clinic offer? A new review has found that mifepristone is the most effective EC method to prevent unwanted pregnancy; however, the drug has not gained U.S. regulatory approval for that use.
-
What can you tell teens about preventing chlamydia? Check the following information from the Centers for Disease Control and Prevention (CDC):
-
-
Have you administered the initial dose of Gardasil, the quadrivalent human papillomavirus (HPV) vaccine, to a young woman with private insurance, only to later discover that her policy does not cover vaccine reimbursement?
-
Circle the dates on your calendar for Reproductive Health 2008, the annual meeting for the Association of Reproductive Health Professionals (ARHP), Planned Parenthood Federation of America, and the Society of Family Planning. The meeting is scheduled for Sept. 17-20 in Washington, DC.
-
With high and rising levels of uninsurance and health care costs, federal and state policy-makers have taken note.
-
Research is eyeing an oral contraceptive (OC) formulation with a new progestin: dienogest. Results of an efficacy trial, presented at the 2008 Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG), indicate the formulation is effective, safe, and well tolerated.
-
The next patient in your office is a 25-year-old mother of two. She's using oral contraceptives (OCs) for birth control, but when you ask her about her method use, she admits she's having problems remembering to take her daily pill.
-
With recent findings that 4% of young women between the ages of 14 and 19 in the United States are infected with chlamydia, public health officials are stepping up efforts to screen more adolescent girls for the sexually transmitted disease (STD).
